JCCSX
Price
$9.00
Change
+$0.05 (+0.56%)
Updated
Feb 4 closing price
Net Assets
892.24M
SKRRX
Price
$6.41
Change
+$0.05 (+0.79%)
Updated
Feb 4 closing price
Net Assets
846.46M
Interact to see
Advertisement

JCCSX vs SKRRX

Header iconJCCSX vs SKRRX Comparison
Open Charts JCCSX vs SKRRXBanner chart's image
ALPS/CorCmdty Mgmt CmpltCmdty Stra A
Price$9.00
Change+$0.05 (+0.56%)
VolumeN/A
Net Assets892.24M
DWS Enhanced Commodity Strategy R6
Price$6.41
Change+$0.05 (+0.79%)
VolumeN/A
Net Assets846.46M
JCCSX vs SKRRX Comparison Chart in %
View a ticker or compare two or three
VS
JCCSX vs. SKRRX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCCSX is a Hold and SKRRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JCCSX has more cash in the bank: 892M vs. SKRRX (846M). JCCSX pays higher dividends than SKRRX: JCCSX (7.93) vs SKRRX (4.94). JCCSX was incepted earlier than SKRRX: JCCSX (8 years) vs SKRRX (10 years). JCCSX (1.50) is less costly to investors than SKRRX (0.94). SKRRX is a more actively managed with annual turnover of: 85.00 vs. JCCSX (19.00). SKRRX has a lower initial minimum investment than JCCSX: SKRRX (0) vs JCCSX (2500). JCCSX annual gain was more profitable for investors over the last year : 32.56 vs. SKRRX (13.44). JCCSX return over 5 years is better than : 78.25 vs. SKRRX (56.67).
JCCSXSKRRXJCCSX / SKRRX
Total Expense Ratio1.400.85165%
Annual Report Gross Expense Ratio1.500.94160%
Fund Existence8 years10 years-
Gain YTD9.9516.891144%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets892M846M105%
Annual Yield % from dividends7.934.94161%
Returns for 1 year32.5613.44242%
Returns for 3 years32.9517.28191%
Returns for 5 years78.2556.67138%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CING6.230.12
+1.96%
Cingulate Inc
TYRA31.240.22
+0.71%
Tyra Biosciences
XFOR4.000.02
+0.50%
X4 Pharmaceuticals Inc
CHSCM25.180.02
+0.08%
CHS
KRYS279.57-2.70
-0.96%
Krystal Biotech